VI
TEVA icon

Vestcor Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Vestcor Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
17,316
+1,231
+8% +$41K 0.01% 720
2026
Q1 		$484K Hold
16,085
– – 0.01% 742
2025
Q4 		$502K Sell
16,085
-2,289
-12% -$56.4K 0.01% 704
2025
Q3 		$371K Sell
18,374
-1,324
-7% -$23.3K 0.01% 820
2025
Q2 		$330K Buy
19,698
+2,802
+17% +$45.2K 0.01% 834
2025
Q1 		$260K Hold
16,896
– – 0.01% 894
2024
Q4 		$372K Buy
16,896
+1,990
+13% +$36.2K 0.01% 786
2024
Q3 		$269K Hold
14,906
– – 0.01% 889
2024
Q2 		$242K Sell
14,906
-2,170
-13% -$33.4K 0.01% 890
2024
Q1 		$241K Hold
17,076
– – 0.01% 899
2023
Q4 		$178K Hold
17,076
– – 0.01% 1016
2023
Q3 		$174K Sell
17,076
-3,061
-15% -$28.5K 0.01% 1031
2023
Q2 		$152K Sell
20,137
-6,358
-24% -$51.6K 0.01% 892
2023
Q1 		$234K Buy
26,495
+1,553
+6% +$15.4K 0.01% 837
2022
Q4 		$227K Hold
24,942
– – 0.01% 891
2022
Q3 		$201K Hold
24,942
– – 0.01% 929
2022
Q2 		$188K Sell
24,942
-3,719
-13% -$32.4K 0.01% 921
2022
Q1 		$269K Sell
28,661
-1,285
-4% -$10.7K 0.01% 846
2021
Q4 		$240K Sell
29,946
-2,688
-8% -$24.3K 0.01% 814
2021
Q3 		$318K Hold
32,634
– – 0.01% 709
2021
Q2 		$323K Hold
32,634
– – 0.01% 741
2021
Q1 		$377K Buy
32,634
+4,564
+16% +$52.3K 0.01% 677
2020
Q4 		$271K Hold
28,070
– – 0.01% 676
2020
Q3 		$253K Hold
28,070
– – 0.01% 621
2020
Q2 		$346K Sell
28,070
-289
-1% -$3.27K 0.02% 495
2020
Q1 		$255K Buy
28,359
+10,504
+59% +$108K 0.01% 565
2019
Q4 		$175K Buy
+17,855
New +$159K 0.01% 720

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Vestcor Inc's TEVA Position: Q2 2026 in Review

Vestcor Inc increased its Teva Pharmaceuticals (TEVA) stake by 7.7% in Q2 2026, buying an estimated $41K and bringing the position to 17,316 shares worth $587K. The position accounts for 0.01% of the portfolio, ranked #720.

Vestcor Inc first reported a position in TEVA in Q4 2019 and has held it in 27 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Vestcor Inc held 17,316 shares of Teva Pharmaceuticals worth $587K as of Q2 2026.
  • Vestcor Inc bought 1,231 Teva Pharmaceuticals shares in Q2 2026, an estimated $41K.
  • Teva Pharmaceuticals made up 0.01% of Vestcor Inc's portfolio in Q2 2026, its #720 holding.
  • Vestcor Inc first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.